Healthcare Equipment and Supplies
Company Overview of Zipline Medical, Inc.
Zipline Medical, Inc. develops and markets non-invasive skin closure solutions. The company’s product, Zip Surgical Skin Closure, is used for application in various medical specialties, including electrophysiology, cardiology, orthopedics, dermatology, emergency medicine, plastic reconstructive surgery, OB/GYN, and general surgery. Zipline Medical, Inc. was founded in 2009 and is based in Campbell, California.
747 Camden Avenue
Campbell, CA 95008
Founded in 2009
Key Executives for Zipline Medical, Inc.
CEO, President & Director
Vice President of Operations
Director of Research & Development
Compensation as of Fiscal Year 2017.
Zipline Medical, Inc. Key Developments
ZipLine Medical, Inc. Announces Results from an Economic Study
Sep 18 17
ZipLine Medical, Inc. announced results from an economic study that showed that Zip Surgical Skin Closure reduced post-discharge costs for total knee arthroplasty (TKA) when compared to staples. Results were presented at the Knee Society Members Meeting by Roger Emerson, MD, of the Texas Center for Joint Replacement, Plano, Texas. The study encompassed 130 consecutive TKA patients, with half of subjects closed with staples and half closed with Zip Surgical Skin Closure. All surgeries were performed at the Texas Center for Joint Replacement by the same surgeon using the same approach and implant, and were closed by the same surgical physician’s assistant. Patients were followed from surgery to first clinic post-operative visit (day 21-28) for assessment. The study findings showed that the Zip reduced all of the following measures when compared to staples: 46% reduction in incision-related actual clinic costs; 60% reduction in incision-related phone calls; 60% reduction in incision-related clinic visits; and 75% reduction in incision-related antibiotics prescribed. In addition, patients found the resulting scar from the Zip to be cosmetically more appealing, and the Zip device less painful to remove, than staples.
ZipLine Medical, Inc. Receives China Food and Drug Administration Approval for Non-Invasive Zip Skin Closure System
Dec 20 16
ZipLine Medical, Inc. announced China Food and Drug Administration (CFDA) approval and commercial availability of its Zip® Surgical Skin Closure device in the region. This clearance will give the company access to the $543 million Chinese wound closure device market serving over 40 million procedures, including growing specialties where the Zip has shown significant benefit, such as orthopedics for total joint replacement and obstetrics for Cesarean-section and hysterectomy procedures. The Zip is a non-invasive, efficient and easy-to-use wound closure device that replaces traditional sutures, staples and glue for surgical incisions and lacerations. It results in a comfortable, secure wound and the device’s unique force distribution system results in high patient comfort and excellent scar quality. The Zip’s micro-adjustability and reversibility provide surgeons with precise control and flexibility during closure. Because application and removal are simple, clinicians can delegate the closure task and, at the clinician’s discretion, patients may remove the Zip at home. Unlike staples or sutures, there are no skin punctures with the Zip, so scarring is minimal and there are no added pathways for bacteria to enter. The Zip’s benefits have been demonstrated in clinical studies in orthopedic total-joint arthroplasty, cardiothoracic surgery, electrophysiology and dermatology.
ZipLine Medical Inc. Announces Publication of Positive Results from the First Prospective, Randomized, Controlled Study of Its Zip Surgical Skin Closure in Pediatric Surgery
Aug 23 16
ZipLine Medical Inc. announced publication of positive results from the first prospective, randomized, controlled study of its Zip® Surgical Skin Closure in pediatric surgery. In the study, the Zip demonstrated significant improvements in scar appearance, efficiency and patient pain compared to suturing. Results were published online in the Annals of Thoracic Surgery. The study of 214 pediatric patients undergoing cardiovascular surgery compared the Zip to continuous subcuticular polypropylene sutures for skin closure at three months. The study found: Significant improvement in scar appearance with the Zip, as evaluated by two plastic surgeons using the Vancouver Scar Scale (VSS) (p). Three times shorter skin closure time with the Zip (113.0 ± 9.1 seconds versus 375.9 ± 60.2 seconds). Significantly fewer patients cried or complained during removal of the Zip (7.1% versus 52.5%,).
Similar Private Companies By Industry
Recent Private Companies Transactions
June 6, 2017